Fractionated Stereotactic Radiotherapy in Patients With Acromegaly

NCT00934271 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34

Last updated 2014-10-28

No results posted yet for this study

Summary

Hypothesis: Fractionated stereotactic radiotherapy is a safe therapy for treatment of patients with acromegaly in terms of both tumour control and biochemical remission

Conditions

Interventions

RADIATION

fractionated stereotactic radiotherapy

Audit of outcome

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2008-01-31
Completion
2008-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00934271 on ClinicalTrials.gov